NARDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nardil, and what generic alternatives are available?
Nardil is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nardil
A generic version of NARDIL was approved as phenelzine sulfate by NOVEL LABS INC on December 8th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NARDIL?
- What are the global sales for NARDIL?
- What is Average Wholesale Price for NARDIL?
Summary for NARDIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,122 |
| Drug Prices: | Drug price information for NARDIL |
| What excipients (inactive ingredients) are in NARDIL? | NARDIL excipients list |
| DailyMed Link: | NARDIL at DailyMed |
Recent Clinical Trials for NARDIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Boehringer Ingelheim | Phase 1 |
| Liverpool Cancer Therapy Centre | Phase 1 |
| The Canberra Hospital | Phase 1 |
Pharmacology for NARDIL
| Drug Class | Monoamine Oxidase Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors |
US Patents and Regulatory Information for NARDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | NARDIL | phenelzine sulfate | TABLET;ORAL | 011909-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
